Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03137472 · ClinicalTrials.gov registry record · NA

TMS for Complex Regional Pain Syndrome

A NA study of Complex Regional Pain Syndromes, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT03137472: Recruiting NA study of Complex Regional Pain Syndromes, sponsored by Stanford University.

NCT03137472 is a NA study of Complex Regional Pain Syndromes that is actively recruiting participants, run by Stanford University. The registered enrollment target is 40 participants, below the 101-participant average among 7 other Complex Regional Pain Syndromes trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03137472, a NA study of Complex Regional Pain Syndromes, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The aim of the current study is to assess the efficacy of TMS in the treatment of Complex Regional Pain Syndrome (CRPS). It is hypothesized that participants who receive TMS (Group 1) relative to sham treatment (Group 2) once daily for two days will demonstrate a greater improvement in CRPS-related pain and other associated symptomology (i.e., cognitive, emotional and physical) compared to baseline. Participants will be followed until they reach their baseline for two consecutive weeks to assess safety and duration of symptom alleviation.

Primary Outcome

Decrease in CRPS-related Pain Ratings

Interventions

  • DEVICE Transcranial Magnetic Stimulation (TMS)

Study Locations (1)

California

  • Stanford Pain Management Center - Redwood City

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2017-04-24
Est. Completion 2026-06-29
Phase NA
Stanford University

1,744 total trials

What NCT03137472 shows while recruiting

NCT03137472 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 101-participant average among 7 other Complex Regional Pain Syndromes trials with a reported enrollment target (60% lower).

The record links to 1 condition, with Complex Regional Pain Syndromes appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Magnetic Stimulation (TMS) is the first listed.

NCT03137472 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03137472 about?

NCT03137472 is a clinical study titled "TMS for Complex Regional Pain Syndrome". The aim of the current study is to assess the efficacy of TMS in the treatment of Complex Regional Pain Syndrome (CRPS). It is hypothesized that participants who receive TMS (Group 1) relative to sham treatment (Group 2) once daily for two days will demonstrate a greater improvement in CRPS-related ...

What is the current status of trial NCT03137472?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2017-04-24. Estimated completion is 2026-06-29.

What conditions does trial NCT03137472 study?

This clinical trial studies the following conditions: Complex Regional Pain Syndromes.

What interventions are being tested in trial NCT03137472?

The interventions under investigation include: Transcranial Magnetic Stimulation (TMS) (DEVICE).

Who is sponsoring clinical trial NCT03137472?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03137472 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Complex Regional Pain Syndromes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03137472, the US trial registry maintained by the National Library of Medicine. NCT03137472 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.